Cargando…
New agent to treat advanced or metastasized thyroid cancer, its efficacy, safety, and mechanism
BACKGROUND: Vandetanib is the first US Food and Drug Administration approved agent to treat advanced or metastasized thyroid cancer. To gain a better understanding of the drug, we conducted a systematic review of its efficacy and safety in patients with thyroid cancers. METHODS: Trial data was retri...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511335/ https://www.ncbi.nlm.nih.gov/pubmed/26273412 http://dx.doi.org/10.1111/1759-7714.12238 |